| A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children BR Del Pozzo-Magana, A Lazo-Langner, B Carleton, LI Castro-Pastrana, ... Journal of Population Therapeutics and Clinical Pharmacology 18 (1), 2011 | 159 | 2011 |
| HLA‐A* 31: 01 and HLA‐B* 15: 02 as genetic markers for carbamazepine hypersensitivity in children U Amstutz, CJD Ross, LI Castro‐Pastrana, MJ Rieder, NH Shear, ... Clinical Pharmacology & Therapeutics 94 (1), 142-149, 2013 | 141 | 2013 |
| Ecofarmacovigilancia en México: perspectivas para su implementación LI Castro-Pastrana, MI Baños-Medina, MA López-Luna, BL Torres-García Revista Mexicana de Ciencias Farmacéuticas 46 (3), 16-40, 2015 | 64 | 2015 |
| Pharmacogenomics of serious adverse drug reactions in pediatric oncology CJD Ross, H Visscher, SR Rassekh, LI Castro-Pastrana, E Shereck, ... Journal of Population Therapeutics and Clinical Pharmacology 18 (1), 2011 | 53 | 2011 |
| Prescription errors in a primary care university unit: urgency of pharmaceutical care in Mexico M Zavaleta-Bustos, LI Castro-Pastrana, I Reyes-Hernández, ... Revista Brasileira de Ciências Farmacêuticas 44, 115-125, 2008 | 44 | 2008 |
| Reacciones adversas a medicamentos relacionadas con ingresos y estancias hospitalarias: revisión sistemática de 2000-2011 SG Salas Rojas, ME Pérez Morales, SG Meléndez López, ... Revista mexicana de ciencias farmacéuticas 43 (3), 19-35, 2012 | 41 | 2012 |
| Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge LI Castro-Pastrana, BC Carleton Journal of Population Therapeutics and Clinical Pharmacology 18 (1), 2011 | 37 | 2011 |
| Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) LI Castro-Pastrana, R Ghannadan, MJ Rieder, E Dahlke, M Hayden, ... Journal of Population Therapeutics and Clinical Pharmacology 18 (1), 2011 | 34 | 2011 |
| Caracterización de la práctica de la atención farmacéutica en instituciones hospitalarias de Santiago de Cuba I Reyes Hernández, IB Bermúdez Camps, LI Castro Pastrana, MA Brice, ... Revista Cubana de Farmacia 47 (2), 225-238, 2013 | 25 | 2013 |
| Effects of effluent from a hospital in Mexico on the embryonic development of zebrafish, Danio rerio P Tenorio-Chávez, M Cerro-López, LI Castro-Pastrana, ... Science of the total environment 727, 138716, 2020 | 24 | 2020 |
| Intravenous administration errors intercepted by smart infusion technology in an adult intensive care unit R Ibarra-Pérez, F Puértolas-Balint, E Lozano-Cruz, SE Zamora-Gómez, ... Journal of Patient Safety 17 (6), 430-436, 2021 | 18 | 2021 |
| Gestión de la calidad en Unidades de Farmacovigilancia Hospitalaria: Propuesta de indicadores de la red ASEGUREMHOS LI Castro-Pastrana, P Pedraza-Montero, R Ortiz-Islas, ... Revista mexicana de ciencias farmacéuticas 45 (1), 57-77, 2014 | 15 | 2014 |
| Ecofarmacovigilancia. MA De Loera-González, SH Sánchez-Rodríguez, LI Castro-Pastrana, ... Revista CENIC: Ciencias Biológicas 47 (1), 12-17, 2016 | 14* | 2016 |
| Análisis de fármacos en aguas residuales de tres hospitales de la ciudad de Puebla, México SSMD Castro-Pastrana LI, Cerro-López M, Toledo-Wall ML, Gómez-Oliván LM Ingeniería del agua 25 (1), 59-73, 2021 | 13* | 2021 |
| Pharmacogenomic investigation of adverse drug reactions (ADRs): the ADR prioritization tool, APT K Shaw, U Amstutz, L Castro-Pastrana, TT Loo, CJ Ross, S Ito, MJ Rieder, ... Journal of Population Therapeutics and Clinical Pharmacology 20 (2), 2013 | 11 | 2013 |
| Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study LC Lopes, M Salas, CGS Osorio‐de‐Castro, LF Leal, SV Doubova, ... Pharmacoepidemiology and drug safety 31 (3), 343-352, 2022 | 10 | 2022 |
| Prevalencia de interacciones farmacológicas en pacientes hospitalizados en el servicio de medicina interna de un hospital general de México E Palacios-Rosas, MP León-Domínguez, LI Castro-Pastrana Anales de la Facultad de Medicina 82 (3), 206-210, 2021 | 7 | 2021 |
| Análisis de costo-efectividad e impacto presupuestal de un programa de atención farmacéutica para pacientes hipertensos de un hospital de tercer nivel de México LI Castro-Pastrana, IF Soria-Cedillo, CE Casco-Castro, M Vallejo-Dennis Revista Mexicana de Ciencias Farmacéuticas 47 (1), 25-42, 2016 | 7 | 2016 |
| Worldwide occurrence, detection, and fate of nonsteroidal anti-inflammatory drugs in water LI Castro-Pastrana, E Palacios-Rosas, ML Toledo-Wall, M Cerro-López Non-Steroidal Anti-Inflammatory Drugs in Water: Emerging Contaminants and …, 2020 | 6 | 2020 |
| Impact of Implementing Smart Infusion Pumps in an Intensive Care Unit in Mexico: A Pre-Post Cost Analysis Based on Intravenous Solutions Consumption E Palacios Rosas, IF Soria-Cedillo, F Puértolas-Balint, R Ibarra-Pérez, ... Hospital Pharmacy 54 (3), 203-208, 2019 | 6 | 2019 |
Bruce CarletonUniversity of British ColumbiaVerified email at popi.ubc.ca
